Avicenna.ai
Avicenna.AI develops cutting-edge artificial intelligence (AI) solutions for emergency radiology and incidental findings detection on CT scans. Their tools automate repetitive tasks, allowing medical professionals to focus on critical cases and improve diagnostic speed and precision. Key products include CINA-ICH for intracranial hemorrhage detection, CINA-LVO for large vessel occlusion, CINA-ASPECTS for stroke quantification, CINA-PE for pulmonary embolism detection, CINA-AD for aortic dissection, CINA-iPE for incidental pulmonary embolism, CINA-VCF for vertebral compression fractures, and CINA-CSpine for cervical spine fractures. The company was founded in 2018 by Cyril Di Grandi and Dr. Peter Chang, and has secured funding rounds to support its growth. Avicenna.AI aims to enhance patient management and radiology workflows through its innovative AI-powered solutions.
Avicenna.ai
Avicenna.AI develops cutting-edge artificial intelligence (AI) solutions for emergency radiology and incidental findings detection on CT scans. Their tools automate repetitive tasks, allowing medical professionals to focus on critical cases and improve diagnostic speed and precision. Key products include CINA-ICH for intracranial hemorrhage detection, CINA-LVO for large vessel occlusion, CINA-ASPECTS for stroke quantification, CINA-PE for pulmonary embolism detection, CINA-AD for aortic dissection, CINA-iPE for incidental pulmonary embolism, CINA-VCF for vertebral compression fractures, and CINA-CSpine for cervical spine fractures. The company was founded in 2018 by Cyril Di Grandi and Dr. Peter Chang, and has secured funding rounds to support its growth. Avicenna.AI aims to enhance patient management and radiology workflows through its innovative AI-powered solutions.